Scott Heimlich, vice president of the Amgen Foundation, discusses his company's involvement with Harvard University's free science education platform LabXchange ...

Amgen is posting strong growth across its diversified-medicines portfolio. A new weight-loss drug candidate could be a game-changer for the company. Trading at 17 times earnings, the stock offers ...

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. It operates through Human Therapeutics segment. The company ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA.

What do Amgen, Biogen, and Takeda have in common? Leaders of research and development at the three biopharma companies shared a stage Thursday at the STAT 2024 Summit in Boston and offered their ...

This forward momentum in the clinical development of obesity treatments is seen as a solid foundation for a positive long-term outlook. Moreover, there are indications that Amgen might be ...

(RTTNews) - Amgen Inc. (AMGN) Tuesday announced positive ... These results will be presented at the Myasthenia Gravis Foundation of America (MGFA) Scientific Session during the American ...

Strategic acquisitions and pipeline expansions remain central to future growth plans. Amgen revealed a positive third quarter of 2024, exceeding earnings expectations. Despite some challenges in ...

Stocks Tumble, Nasdaq 100 Selloffs As Tech Giants Disappoint, Crypto Companies Plummet: What's Driving Markets Thursday? Risk aversion swept across markets on Thursday as investor disappointment ...

Amgen (AMGN) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Over the ...

Oct. 15, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN ... parallel-group trial will be presented at the Myasthenia Gravis Foundation of America (MGFA) Scientific Session during the American Association ...